CEO power and integrated reporting

PurposeThis study aims to analyse the role that the chief executive officer (CEO) has on integrated reporting (IR) adoption and whether this role is moderated by incentives to promote corporate transparency, including information asymmetry problems and financial constraints. IR represents the last f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Meditari Accountancy Research 2021-08, Vol.29 (4), p.908-942
Hauptverfasser: Garcia-Sanchez, Isabel-Maria, Raimo, Nicola, Vitolla, Filippo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PurposeThis study aims to analyse the role that the chief executive officer (CEO) has on integrated reporting (IR) adoption and whether this role is moderated by incentives to promote corporate transparency, including information asymmetry problems and financial constraints. IR represents the last frontier of corporate disclosure and aims to represent, through the annual integrated report, the ability of an organization to create value over time.Design/methodology/approachThis study is based on 10,819 observations (an unbalanced data panel of 1,588 firms for the period 2009–2017). A logistic regression model is used to examine the association between CEO power and disclosure of an integrated report.FindingsThe results show that CEOs with greater power oppose the disclosure of integrated information, and this behaviour is not modified by firms’ incentives. Furthermore, greater growth opportunities increase CEO opposition to disclosing integrated information on the creation of value, perhaps as a consequence of the possible use of it by competitors.Originality/valueThis study contributes to the existing literature. First, it expands the scientific debate on the topic of IR. Second, it extends the application field of agency theory, which is seldom used to explain the phenomena related to IR.
ISSN:2049-372X
2049-3738
DOI:10.1108/MEDAR-11-2019-0604